Generic Drug Facts | FDA
2021年11月1日 · Generic drugs: Get the facts. Consumer-friendly text and graphics provide a few facts about generic drug approval, quality, and performance.
Generic Drugs | FDA - U.S. Food and Drug Administration
Understanding generic drugs. Consumer-friendly information on the safe and effective use of generic drugs.
Complex Generics News - U.S. Food and Drug Administration
2024年11月22日 · Generally, complex generics are products that have complex active ingredients, formulations, dosage forms, or routes of administration, or are complex drug-device combination products. Generics of ...
FDA List of Authorized Generic Drugs - U.S. Food and Drug …
2024年10月8日 · The FDA List of Authorized Generics page answers what an authorized generic is and how it differs from a traditional generic. An authorized generic is used to describe an approved brand name drug ...
The Generic Drug Approval Process - U.S. Food and Drug …
Usually, as FDA approves more generics of a brand-name drug, the cost drops. Generally, multiple generic drugs for the same product create marketplace competition.
Generic Drugs: Questions & Answers | FDA - U.S. Food and Drug ...
A generic drug is a medication created to be the same as an already marketed brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics, and ...
First Generic Drug Approvals | FDA
2024年11月25日 · “First generics” are just what they sound like—the first approval by FDA which permits a manufacturer to market a generic drug product in the United States. FDA considers first generics to ...
Generic Competition and Drug Prices - U.S. Food and Drug …
2024年10月17日 · Estimated Savings from Generic Drug Approvals We recognize that there has been increasing attention on whether the lower cost of generic drugs, especially as more generics enter the market over ...
Office of Generic Drugs 2021 Annual Report - U.S. Food and Drug ...
2022年2月14日 · Welcome to the seventh Annual Report from the Office of Generic Drugs (OGD) in the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA).
FDA Approves First Generic of Once-Daily GLP-1 Injection to …
FDA approved the first generic referencing Victoza (liraglutide injection) 18 mg/3 mL, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and ...